Clinical Trial Update: Open-label, Randomized Study in a Pediatric Population in a JEV (Japanese Encephalitis Virus)-Endemic Country [Phase 3]

View source ↗

Summary

Open-label, randomized Phase 3 trial of a Japanese Encephalitis vaccine in pediatric participants in an endemic country; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Japanese Encephalitis

Drugs mentioned

• Valneva Japanese Encephalitis Vaccine (candidate) (Japanese encephalitis vaccine)

Snippet

Sponsor: Valneva Austria GmbH | Conditions: Japanese Encephalitis | Phase 3 | Status: COMPLETED | Results posted: 2014-12-19